- Home
- WY vs STE Comparison
WY vs STE Comparison
Compare WY & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WY
- STE
- Stock Information
- Founded
- WY 1900
- STE 1985
- Country
- WY United States
- STE United States
- Employees
- WY N/A
- STE N/A
- Industry
- WY Real Estate Investment Trusts
- STE Industrial Specialties
- Sector
- WY Real Estate
- STE Health Care
- Exchange
- WY Nasdaq
- STE Nasdaq
- Market Cap
- WY N/A
- STE 22.1B
- IPO Year
- WY N/A
- STE 1992
- Fundamental
- Price
- WY $31.98
- STE $218.88
- Analyst Decision
- WY Buy
- STE Buy
- Analyst Count
- WY 6
- STE 6
- Target Price
- WY $36.33
- STE $253.00
- AVG Volume (30 Days)
- WY 2.9M
- STE 737.0K
- Earning Date
- WY 01-23-2025
- STE 11-06-2024
- Dividend Yield
- WY 2.50%
- STE 1.04%
- EPS Growth
- WY N/A
- STE N/A
- EPS
- WY 0.73
- STE 4.37
- Revenue
- WY $7,190,000,000.00
- STE $5,325,525,000.00
- Revenue This Year
- WY N/A
- STE $7.91
- Revenue Next Year
- WY $8.08
- STE $6.37
- P/E Ratio
- WY $43.79
- STE $36.82
- Revenue Growth
- WY N/A
- STE 15.75
- 52 Week Low
- WY $26.73
- STE $195.50
- 52 Week High
- WY $36.27
- STE $248.24
- Technical
- Relative Strength Index (RSI)
- WY 53.76
- STE 47.10
- Support Level
- WY $30.35
- STE $213.31
- Resistance Level
- WY $32.55
- STE $218.38
- Average True Range (ATR)
- WY 0.49
- STE 3.62
- MACD
- WY 0.18
- STE 0.53
- Stochastic Oscillator
- WY 73.09
- STE 62.18
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.